Goldman Sachs analyst Gustavo Miele downgraded Blau Farmaceutica (BLAU3:BZ) from Buy to Sell with a price target of R$10.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE